U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Food
  3. Dietary Supplements
  4. Information on Select Dietary Supplement Ingredients and Other Substances
  5. BMPEA in Dietary Supplements
  1. Information on Select Dietary Supplement Ingredients and Other Substances

BMPEA in Dietary Supplements

BMPEA is a substance that does not meet the statutory definition of a dietary ingredient. The Federal Food, Drug, and Cosmetic Act defines a dietary ingredient as a vitamin; mineral; herb or other botanical; amino acid; dietary substance for use by man to supplement the diet by increasing the total dietary intake; or a concentrate, metabolite, constituent, extract, or combination of the preceding substances. BMPEA is none of these, rendering misbranded any products that declare BMPEA as a dietary supplement.

BMPEA is also known as:

  • βMePEA
  • R-beta-methylphenethylamine
  • R-beta-methylphenethylamine HCl
  • Beta-methylphenethylamine
  • β-methylphenylethylamine
  • 1-amino-2-phenylpropane
  • 2-phenylpropan-1-amine
  • 2-phenylpropylamine
  • alpha-benzylethylamine
  • 1-phenyl-1-methyl-2-aminoethane
  •  
  • beta-methylbenzeneethanamine
  • beta-phenylpropylamine
  • 2- phenyl-1-propanamine

For More Information:

This webpage describes FDA’s views and recent actions with regard to an ingredient used in products marketed as dietary supplements.  If you have evidence that calls FDA’s views into question, we invite you to submit it, along with your reasoning, to FDA at ODSP@fda.hhs.gov.

This page is not intended to provide a complete list of all FDA actions and communications with regard to this ingredient and its use in products marketed as dietary supplements.

Back to Top